Zoetis Inc. Files 8-K on Dec 11, 2025

Ticker: ZTS · Form: 8-K · Filed: 2025-12-11T00:00:00.000Z

Sentiment: neutral

Topics: sec-filing, regulation-fd, financial-reporting

Related Tickers: ZTS

TL;DR

Zoetis filed an 8-K today, check for updates.

AI Summary

Zoetis Inc. filed an 8-K on December 11, 2025, reporting on events that occurred on the same date. The filing primarily concerns Regulation FD Disclosure and Financial Statements and Exhibits. No specific financial figures or material events beyond the filing itself are detailed in this excerpt.

Why It Matters

This 8-K filing indicates that Zoetis Inc. is making disclosures required by the SEC, which could include important updates for investors.

Risk Assessment

Risk Level: low — This filing is a routine SEC disclosure and does not contain specific negative or positive material information in the provided text.

Key Players & Entities

FAQ

What is the primary purpose of this 8-K filing by Zoetis Inc.?

The primary purpose of this 8-K filing is for Regulation FD Disclosure and to report on Financial Statements and Exhibits, as indicated by the filing information.

On what date was this 8-K report filed and what is the earliest event date reported?

The 8-K report was filed on December 11, 2025, and the earliest event reported is also December 11, 2025.

What is Zoetis Inc.'s principal executive office address?

Zoetis Inc.'s principal executive office is located at 10 Sylvan Way, Parsippany, New Jersey 07054.

What is Zoetis Inc.'s SEC File Number?

Zoetis Inc.'s SEC File Number is 001-35797.

What is Zoetis Inc.'s I.R.S. Employer Identification Number?

Zoetis Inc.'s I.R.S. Employer Identification Number is 46-0696167.

From the Filing

0001555280-25-000282.txt : 20251211 0001555280-25-000282.hdr.sgml : 20251211 20251211161725 ACCESSION NUMBER: 0001555280-25-000282 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 14 CONFORMED PERIOD OF REPORT: 20251211 ITEM INFORMATION: Regulation FD Disclosure ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20251211 DATE AS OF CHANGE: 20251211 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Zoetis Inc. CENTRAL INDEX KEY: 0001555280 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences EIN: 460696167 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-35797 FILM NUMBER: 251565197 BUSINESS ADDRESS: STREET 1: 10 SYLVAN WAY CITY: PARSIPPANY STATE: NJ ZIP: 07054 BUSINESS PHONE: 973-822-7000 MAIL ADDRESS: STREET 1: 10 SYLVAN WAY CITY: PARSIPPANY STATE: NJ ZIP: 07054 8-K 1 zts-20251211.htm 8-K zts-20251211 0001555280 false 0001555280 2025-12-11 2025-12-11 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C.  20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): December 11, 2025 Zoetis Inc. (Exact name of registrant as specified in its charter) Delaware 001-35797 46-0696167 (State or other jurisdiction (Commission File (I.R.S. Employer of incorporation) Number) Identification No.) 10 Sylvan Way Parsippany New Jersey 07054 (Address of principal executive offices) (Zip Code) ( 973 ) 822-7000 (Registrant's telephone number, including area code) Not Applicable (Former Name or Former Address, if changed since last report) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the obligation of the registrant under any of the following provisions (see General Instruction A.2. below): ☐     Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425) ☐     Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) ☐     Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2 (b)) ☐     Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Title of each class Trading Symbol(s) Name of each exchange on which registered Common Stock, par value $0.01 per share ZTS New York Stock Exchange Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).                                      Emerging growth company ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐ Item 7.01. Regulation FD Disclosure. On December 11, 2025, the Company declared a dividend of $0.53 per share for the first quarter of 2026. The dividend will be paid on March 3, 2026, to all holders of record of the Company’s common stock as of the close of business on January 20, 2026. The information set forth under this Item 7.01, including Exhibit 99.1, shall not be deemed “filed” for purposes of the Securities Exchange Act of 1934, as amended, or incorporated by reference in any filing under the Securities Act of 1933, as amended, regardless of any general incorporation language in such filing, unless expressly i

View on Read The Filing